Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1β
- 16 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (12) , 4357-4363
- https://doi.org/10.1161/01.cir.96.12.4357
Abstract
Background Although coronary artery spasm plays an important role in a wide variety of ischemic heart diseases, the intracellular mechanism for the spasm remains to be clarified. We examined the role of myosin light chain (MLC) phosphorylations, a key mechanism for contraction of vascular smooth muscle, in our swine model with interleukin-1β (IL-1β). Methods and Results IL-1β was applied chronically to the porcine coronary arteries from the adventitia to induce an inflammatory/proliferative lesion. Two weeks after the operation, intracoronary serotonin repeatedly induced coronary hyperconstrictions at the IL-1β-treated site both in vivo and in vitro, which were markedly inhibited by fasudil, an inhibitor of protein kinases, including protein kinase C and MLC kinase. Western blot analysis showed that during serotonin-induced contractions, MLC monophosphorylation was significantly increased and sustained in the spastic segment compared with the control segment, whereas MLC diphosphorylation was noted only in the spastic segment. A significant correlation was noted between the serotonin-induced contractions and MLC phosphorylations. Both types of MLC phosphorylation were markedly inhibited by fasudil. In addition, MLC diphosphorylation was never induced by a simple endothelium removal in the normal coronary artery, whereas enhanced MLC phosphorylations in the spastic segment were noted regardless of the presence or absence of the endothelium. Conclusions These results indicate that enhanced MLC phosphorylations in the vascular smooth muscle play a central role in the pathogenesis of coronary spasm in our swine model.Keywords
This publication has 21 references indexed in Scilit:
- Inflammatory Cytokines Cause Coronary Arteriosclerosis-Like Changes and Alterations in the Smooth-Muscle Phenotypes in PigsJournal of Cardiovascular Pharmacology, 1997
- Central role of vascular smooth muscle hyperreactivity in coronary hyperconstriction after balloon injury in miniature pigsCoronary Artery Disease, 1997
- Intracellular Calcium, Myosin Light Chain Phosphorylation, and Contractile Force in Experimental Cerebral VasospasmNeurosurgery, 1996
- Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.Journal of Clinical Investigation, 1996
- Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo.Journal of Clinical Investigation, 1995
- Involvement of rho in GTPγS‐induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activityFEBS Letters, 1995
- Signal transduction and regulation in smooth muscleNature, 1994
- Regulation of Smooth Muscle Contractile Elements by Second MessengersAnnual Review of Physiology, 1989
- Coronary Artery Spasm Induced in Atherosclerotic Miniature SwineScience, 1983
- “Variant” angina: One aspect of a continuous spectrum of vasospastic myocardial ischemiaThe American Journal of Cardiology, 1978